Document is current
Any future updates will be listed below
-
Authors
Sanin, A. V.
Pronin, A. V.
Narovlyanskiy, A. N.
Ozherelkov, S. V.
Sedov, A. M.
- License Information
-
More Information
Article History
Received: 9 March 2022
Revised: 13 March 2022
Accepted: 25 March 2022
First Online: 14 December 2022
COMPLIANCE WITH ETHICAL STANDARDS
: Conflict of Interests
: The authors declare the existence of a conflict of interest. A.V. Pronin, A.N. Narovlyansky, A.V. Sanin, and S.V. Ozherelkov participated in the theoretical development and practical use of the drugs Phosprenyl and Gamapren, and A.V. Pronin, A.N. Narovlyansky, and A.V. Sanin are also the developers of the medical drug Fortepren®, which is registered by the Ministry of Health of the Russian Federation.
: All applicable international, national and/or institutional guidelines for the care and use of animals have been observed.
